Cambodia's pharmaceutical market is underdeveloped. This, coupled with competition from neighbouring countries such as Vietnam and Thailand, means that the country is not a main focus for many multinational pharmaceutical companies looking to develop their presence in the region. In 2017, total pharmaceutical sales reached KHR1,192.4bn (USD294mn), with per capita spending reaching USD18.4. Pharmaceutical sales represent 23.7% of expenditure on healthcare and 1.3% of GDP. Total healthcare expenditure reached KHR5,034.1bn (USD1.2bn) in 2017, of which only 30% was government health expenditure and the remaining KHR3,548.3bn (USD875mn) private health spending. Per capita health expenditure reached USD77 and health expenditure represented 5.6% of GDP in 2017.

Key View

SWOT

Industry Forecast

Industry Risk/Reward Index

Regulatory Development

Market Overview

Competitive Landscape

Company Profile

Cambodia Demographic Outlook

Pharmaceuticals & Healthcare Glossary

Pharmaceuticals & Healthcare Methodology